Immunization Economics Webinar Series

September 15, 2021 - November 17, 2021

The International Health Economics Association (iHEA) Special Interest Group (SIG) on Immunization Economics launches its inaugural webinar series this Fall 2021, focused on current research relevant to the immunization economics community of practice. The series includes six talks on Wednesdays from September 15 through November 17. Presenters will include researchers at Harvard University, Johns Hopkins University, London School of Hygiene and Tropical Medicine, University of Ghana, PATH, and Imperial College London. Attendance is open to all.

 

September 15, 12pm EDT / 4pm GMT [registration link is open]
Stephen C. Resch
Harvard T.H. Chan School of Public Health
”Estimating the cost of delivering COVID-19 vaccine in COVAX 92 AMC countries”

September 22, 8am EDT / 12pm GMT [registration link is open]
Kaja Abbas, Han Fu, and Mark Jit
London School of Hygiene and Tropical Medicine
”Disruptions to childhood immunization during the COVID-19 pandemic: health impact modeling and economic perspectives”

October 6, 12pm EDT / 4pm GMT
Bryan Patenaude
Johns Hopkins Bloomberg School of Public Health
”Measuring in vaccination coverage & cost-of-illness: an introduction to the VERSE toolkit”

October 20, 8am EDT / 12pm GMT
Justice Nonvignon
University of Ghana
”Costing of COVID-19 vaccine introduction and deployment: lessons from Ghana”

November 3, 12pm EDT / 4pm GMT
Ranju Baral
PATH
”Costs of RTS,S malaria vaccination in the three malaria vaccine implementation countries”

November 17, 8am EST / 1pm GMT
Katharina Hauck
Imperial College London
”Integrating economic and epidemiological objectives in the optimal response to pandemics: the role of analytical modeling”

For more information please visit https://www.healtheconomics.org/events/event_list.asp#

You May Also Like

Linked Webinar on One-dose HPV vaccination: Evidence, lessons learned and strategies, with experiences from Guyana and Estonia

Choosing or switching to a single dose HPV vaccination can simplify delivery and lower program costs. It can also help reduce the potential for supply shortages and alleviate delivery challenges such as those encountered during the COVID-19 pandemic. Whether countries are in the initial stages of introducing the HPV vaccine or considering a switch, they … Read More

How to leverage market intelligence, including demand and country-specific disease information, for national decision-making and product choice

The Vaccine Procurement Practitioners Network (VPPN) invites you to their second webinar of a 3-part series, which will be held on Thursday, 19 September 2024, from 10am to 10.45am GMT+2, in English, Russian and French. Covering how market intelligence can be leveraged for national decision-making and vaccine product choice, this webinar will feature Procurement Service Manager … Read More

Europe and Central Asia countries tell us how they leverage market intelligence for their vaccine procurement strategy part 2

This is the second webinar of a 3-part series, which will be held on Thursday, 19 September 2024, from 10am to 10.45am GMT+2, in English, Russian and French. Covering how market intelligence can be leveraged for national decision-making and vaccine product choice, this webinar will feature Procurement Service Manager Eveli Bauer, from the Health Insurance … Read More